Cargando…
Antibody-mediated blockade of the IL23 receptor destabilizes intratumoral regulatory T cells and enhances immunotherapy
Regulatory T cells (Treg) can impede antitumor immunity and currently represent a major obstacle to effective cancer immunotherapy. Targeting tumor-infiltrating regulatory Treg while sparing systemic Treg represents an optimal approach to this problem. Here, we provide evidence that the interleukin...
Autores principales: | Wight, Andrew E., Sido, Jessica M., Degryse, Sandrine, Ao, Lin, Nakagawa, Hidetoshi, Qiu(Vivian), Yiguo, Shen, Xianli, Oseghali, Oba, Kim, Hye-Jung, Cantor, Harvey |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Academy of Sciences
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9170135/ https://www.ncbi.nlm.nih.gov/pubmed/35482921 http://dx.doi.org/10.1073/pnas.2200757119 |
Ejemplares similares
-
Definition of a mouse microglial subset that regulates neuronal development and proinflammatory responses in the brain
por: Shen, Xianli, et al.
Publicado: (2022) -
Repurposing infectious disease vaccines for intratumoral immunotherapy
por: Melero, Ignacio, et al.
Publicado: (2020) -
Anti-CTLA-4 antibodies in cancer immunotherapy: selective depletion of intratumoral regulatory T cells or checkpoint blockade?
por: Tang, Fei, et al.
Publicado: (2018) -
Definition of the contribution of an Osteopontin-producing CD11c(+) microglial subset to Alzheimer’s disease
por: Qiu, Yiguo, et al.
Publicado: (2023) -
Intratumoral Immunotherapy—Update 2019
por: Hamid, Omid, et al.
Publicado: (2019)